Local delivery of nadroparin via hydrogel-coated angioplasty balloon: effect on platelet deposition and smooth muscle cell proliferation--an experimental study.

[1]  J. Fisher,et al.  Factors Determining Hydrogel Permeability , 1997, Annals of the New York Academy of Sciences.

[2]  J. Bosch,et al.  Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. , 1997, Radiology.

[3]  A. Baumbach,et al.  Time course of smooth muscle cell proliferation after local drug delivery of low-molecular-weight heparin using a porous balloon catheter. , 1997, Catheterization and cardiovascular diagnosis.

[4]  R. Davis,et al.  Nadroparin Calcium , 1997, Drugs & aging.

[5]  A. Turpie.  Low-molecular-weight heparin: from the bench to the orthopedic patient. , 1997, Orthopedics.

[6]  D. Mikhailidis,et al.  low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin‐induced platelet shape change and does not enhance spontaneous platelet aggregation , 1996 .

[7]  A. Frydman,et al.  Comparison of the Pharmacokinetic Profiles of Three Low Molecular Mass Heparins – Dalteparin, Enoxaparin and Nadroparin – Administered Subcutaneously in Healthy Volunteers (Doses for Prevention of Thromboembolism) , 1995, Thrombosis and Haemostasis.

[8]  G. Cattoretti,et al.  Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  J. Barry,et al.  Local delivery of an antiproliferative drug with use of hydrogel-coated angioplasty balloons. , 1994, Journal of vascular and interventional radiology : JVIR.

[10]  D. Waters,et al.  Decreased Platelet Deposition and Smooth Muscle Cell Proliferation After Intramural Heparin Delivery With Hydrogel‐Coated Balloons , 1994, Circulation.

[11]  S. King,et al.  Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. , 1994, Journal of the American College of Cardiology.

[12]  D. Waters,et al.  Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. , 1994, Journal of the American College of Cardiology.

[13]  J. Isner,et al.  Prospects for site-specific delivery of pharmacologic and molecular therapies. , 1994, Journal of the American College of Cardiology.

[14]  E. Edelman,et al.  Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. , 1993, Circulation research.

[15]  J. Isner,et al.  Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. , 1993, Human gene therapy.

[16]  Johannes Gerdes,et al.  Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections , 1993, The Journal of pathology.

[17]  M. Karnovsky,et al.  Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. , 1993, The Journal of biological chemistry.

[18]  H. Lundqvist,et al.  Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives , 1993, Journal of internal medicine.

[19]  N. Olson,et al.  Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. , 1992, The Journal of clinical investigation.

[20]  A. Michelson,et al.  High-dose heparin suppresses platelet alpha granule secretion. , 1992, Journal of vascular surgery.

[21]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  M. Reidy,et al.  Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia--a review. , 1991, Journal of vascular surgery.

[23]  K. Karsch,et al.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.

[24]  A. Clowes,et al.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. , 1990, The American journal of pathology.

[25]  E. Edelman,et al.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Mayberg,et al.  Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation. , 1989, Neurosurgery.

[27]  A. Clowes,et al.  Kinetics of Cellular Proliferation after Arterial Injury: IV. Heparin Inhibits Rat Smooth Muscle Mitogenesis and Migration , 1986, Circulation research.

[28]  A. Clowes,et al.  Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycans , 1984, Journal of cellular physiology.

[29]  D. Waters,et al.  Methylene blue inhibits the antithrombotic effect of nitroglycerin. , 1993, Journal of the American College of Cardiology.